Avricore Health Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was CAD 0.953454 million compared to CAD 0.572228 million a year ago. Net loss was CAD 0.285062 million compared to CAD 0.180398 million a year ago.
For the nine months, sales was CAD 2.13 million compared to CAD 0.791139 million a year ago. Net loss was CAD 0.760799 million compared to CAD 0.573439 million a year ago. Basic loss per share from continuing operations was CAD 0.01.